Well you don't need a trading halt to release that dosing has been completed.
Interim analysis ? Never know but I'd say unlikely while dosing of all patients has not yet been completed & even the first patients dosed would not yet have passed the 8 week period post dosing.
Status of the trial ? ?
>> still not fully enrolled so pushing dates out ?
>> stuff up in protocol ? - a lot of different sites for a small trial 5 UK, 2 Spain, France - it's probably not unreasonable too assume that they may not of all been implemented the same across sites ?
>> adverse safety event ? the dosing is heavier than Phase I
I've really got no idea but that's probably what comes to mind. Sure there will be speculation like the great wall china between now an then lol
As others have said a bit questionable with the 20M+ stock dumped leading into the halt.
ANP Price at posting:
16.0¢ Sentiment: None Disclosure: Held
